CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 288 enrolled
Drug / intervention
Interventiondrug
Likely dose
Intervention 30 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03395912
NCT03395912N/ACompleted

Efficacy of a Single-shot Wound Infiltration With Bupivacaine/Adrenalin During Cesarean Section in Reducing Postoperative Pain. A Randomized Prospective Controlled Trial

HaEmek Medical Center, Israel·interventional·Posted Jan 10, 2018·Updated Oct 19, 2022

In Brief

A clinical study evaluating Intervention for Cesarean Section. Completed, enrolled 288 participants across 1 site.

Detailed Summary

Thus study evaluates the advantage of infiltration of the surgical wound by local anesthetics in cesarean section on post operative pain relief. In the study group before closing the skin, both sides of the incision (top and bottom) will be infiltrated by 30 ml of 0.25% BUPIVACAINE and ADRENALIN at 1: 200,000 concentration and then closing the skin. In the control group, the skin will be closed without infiltration. Our hypothesis is that subcutaneous infiltration of the surgical wound by BUPIVACAINE + ADRENALIN at the end of cesarean section will reduce the intensity of post operative pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesIsrael
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 10, 2018
Enrollment StartJan 25, 2018
Primary CompletionMay 30, 2020
Study CompletionJun 30, 2021
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 8.5 years ago

Interventions

Interventiondrug

After closing the fascia above the rectus muscles, and before closing the skin, the subcutaneous layer will be infiltrated on both sides of the incision (top and bottom) by 30 ml of 0.25% BUPIVACAINE and ADRENALIN at 1: 200,000 concentration and then closing the skin.